RxDoctor Payments Data

Zachary Sites, PA

Physician Assistant · Ashburn, VANPI 1518620848

Payments from drug & device makers

$5,529in general payments, 2019–2025

Across 104 payments — averaging $53.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Abbott$1K
  • E.r. Squibb & Sons, L.L.C.$525
  • Boston Scientific$302
  • Boehringer Ingelheim$232
  • Novartis$172
  • plus $739 from 11 others

What the payments were for

  • Travel & lodging$2,68549%
  • Food & beverage$2,84351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,529 in reported general payments places this provider in the 90th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Medicare billing

Part B allowed, 2024
$79,681
Medicare patients
491
Services billed
971

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban117$138,590
EntrestoSacubitril/Valsartan49$53,501
Repatha SureclickEvolocumab42$33,220
XareltoRivaroxaban16$17,329
JardianceEmpagliflozin20$16,632
BrilintaTicagrelor12$10,040
Repatha SyringeEvolocumab15$8,022
Ranolazine ErRanolazine32$2,749
Prasugrel Hcl24$2,591
Metoprolol Succinate216$2,144
Atorvastatin Calcium122$1,273
Isosorbide Mononitrate ErIsosorbide Mononitrate117$1,233
Amiodarone Hcl34$1,173
Rosuvastatin Calcium98$1,162
Ezetimibe52$1,128

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$71$138,590117 claims
NovartisEntresto$172$53,50149 claims
Johnson & JohnsonXarelto$68$17,32916 claims
Boehringer IngelheimJardiance$232$16,63220 claims
AstraZenecaBrilinta$141$10,04012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Ashburn

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →